Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy. - Barron's
1. Trump promises drug tariffs, but perceptions of their impact are declining. 2. Merck's stock increased 1.05% amidst tariff uncertainty. 3. Stockpiling allows companies to mitigate short-term tariff impacts. 4. Delays in tariff implementation offer time for companies to adapt. 5. Analysts view tariffs as manageable risks for pharma stocks.